Advanced Tissue Sciences' TransCyte
This article was originally published in The Gray Sheet
Executive Summary
Bioengineered human skin was approved in 1997, not 1996 as was reported in "The Gray Sheet" (April 26, p. 7). In addition, the firm's Dermagraft product, not TransCyte, is approved in the U.K. and Canada as a treatment for diabetic foot ulcers